Pfizer has responded after a Brisbane man was hospitalised with blood clots simply days after receiving the pharmaceutical big’s COVID vaccine.
The 40-year-old, who works as a police officer in a quarantine resort, introduced at a non-public hospital on Wednesday struggling clots, after being jabbed on Sunday.
It was later revealed the person had additionally just lately undergone knee surgical procedure, which is believed to be the extra possible reason for the blood clots.
In a press release, Pfizer stated they’d carried out a “complete evaluation of ongoing mixture security information” for the Pfizer-BioNTech vaccine, of which 200 million doses have been administered throughout the globe.
“(This has) offered no proof to conclude that arterial or venous thromboembolic occasions (blood clots), with or with out thrombocytopenia, are a danger related to using our COVID-19 vaccine,” the corporate stated.
“This security database evaluation included a overview of all antagonistic occasions obtained for the vaccine by means of to March 27,2021.
“The protection of our vaccine is paramount.”
The Therapeutic Items Administration and Queensland Well being are investigating the case.
Up to now, Australia has recorded three circumstances of blood clotting linked to the AstraZeneva vaccine, which led the Australian Technical Advisory Group on Immunisation to alter its steerage for folks underneath 50, with a desire for Pfizer.
Extra to come back